Research changes the world.
Emily is the communication specialist for the Ragon Institute of MGH, Harvard and MIT, where she combines her love for science and writing.
The good news is that most strokes are preventable, treatable and beatable, says Natalia Rost, MD, MPH, Chief of the Stroke Division.
Scovil was one of the first nurses to be formally trained at Mass General and was a prolific author and advice columnist for women.
Dr. Tohyama is studying the brain mechanisms of patients with chronic pain and loves using her creativity to answer research questions.
TEMPOS is a user-friendly rating scale that can be used to assess adherence to reporting recommendations.
Mass General researchers are testing the psychedelic compound psilocybin as a therapeutic for treatment-resistant depression.
Dr. Apiou’s focus is on teaching and practicing unique models of innovation through collaboration across academia and industry.
A unique collaborative effort seeks to reduce the environmental impact of biomedical research.
Dr. Ruiz is studying the interactions of the immune system with tumor cells in the brain and neck. He also loves dancing and bike riding.
Despite being a treatable disease, osteoporosis remains underdiagnosed and undertreated, with Black women experiencing the most disparities.